Ken Griffin’s First Tracks Biotherapeutics TRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.1M Buy
624,142
+455,352
+270% +$17.8M ﹤0.01% 2494
2026
Q2
$3.4M Buy
+168,790
New +$3.16M ﹤0.01% 5441

Other funds holding TRAX

Ken Griffin's TRAX Position: Q3 2026 in Review

Ken Griffin increased its First Tracks Biotherapeutics (TRAX) stake by 270% in Q3 2026, buying an estimated $17.8M and bringing the position to 624,142 shares worth $22.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Ken Griffin first reported a position in TRAX in Q2 2026 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.

  • Ken Griffin held 624,142 shares of First Tracks Biotherapeutics worth $22.1M as of Q3 2026.
  • Ken Griffin bought 455,352 First Tracks Biotherapeutics shares in Q3 2026, an estimated $17.8M.
  • First Tracks Biotherapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #2494 holding.
  • Ken Griffin first reported a position in First Tracks Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
  • 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.